• Bestatin Hydrochloride: From Enzymes to Translation

  2026-08-17

  Bestatin hydrochloride, also known as Ubenimex, is more than a generic aminopeptidase inhibitor. Its ability to perturb aminopeptidase N and B activity creates a practical bridge between neuronal peptide processing, angiogenesis inhibition, and translational cancer research. This article examines the evidence, experimental design implications, and strategic opportunities for using the compound responsibly.

• Melittin Workflows for Glioblastoma Signaling

  2026-08-17

  Use Melittin as a dual-action GPCR signaling probe while separating pathway modulation from nonspecific loss of cell viability. This workflow connects Gs/Gi analysis with glioblastoma migration, apoptosis, and ferroptosis-oriented assay design without treating the peptide as a direct substitute for genetic or lipid-pathway manipulation.

• Ionomycin free acid in Reliable Cell Assays

  2026-08-16

  Learn how Ionomycin free acid (SKU B6947) can support controlled calcium ion transport, assay optimization, and interpretation of viability or proliferation data. This scenario-based guide connects product handling with practical controls and carefully distinguishes established product information from exploratory TNBC applications.

• Cannabidiol, FAAH, and Orofacial Pain Affective Deficits

  2026-08-15

  This mouse study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-associated affective and cognitive deficits through coordinated peripheral and central mechanisms. Its findings connect FAAH-related endocannabinoid signaling, CB1 and CB2 receptor pathways, inflammatory mediators, and serotonergic activity, while also clarifying important limits for translation.

• Capecitabine in Gastric Cancer Assembloid Research

  2026-08-14

  Capecitabine offers a practical way to test tumor-selective fluoropyrimidine activation in patient-derived organoid and stromal co-culture systems. This workflow pairs viability measurements with thymidine phosphorylase, Fas, and tumor–stroma readouts to expose resistance mechanisms that monocultures can miss.

• Patient-Derived Spheroids in Organ-Confined Prostate Cancer

  2026-08-14

  Linxweiler and colleagues established viable three-dimensional spheroid cultures from radical prostatectomy specimens, creating a patient-derived model for studying organ-confined prostate cancer. The cultures retained clinically relevant markers, could be cryopreserved, and displayed differential responses to androgen receptor antagonists and cytotoxic treatment, supporting their use in translational prostate cancer research.

• Tadalafil-Primed Exosomes in Pulmonary Hypertension

  2026-08-13

  The reference study shows that tadalafil pretreatment changes mesenchymal stem cell exosome activity, improving anti-inflammatory and anti-remodeling effects in hypoxia-associated pulmonary hypertension. Its mechanistic model connects CREB1-regulated miR-29a-3p with ENPP2 and endothelial exosome signaling, providing a framework for evaluating engineered or pharmacologically conditioned extracellular vesicles.

• AZD1480: Blocking Tumor-Protective JAK2/STAT3

  2026-08-13

  IDO1 blockade can produce an unexpected IL-6–JAK2–STAT3 survival signal in tumor cells. This thought-leadership guide explains how AZD1480 can test that adaptive resistance mechanism, connect pathway engagement to tumor phenotypes, and strengthen translational study design without overstating preclinical evidence.

• GPR30 in Spinal CCK+ Neurons and Neuropathic Pain

  2026-08-12

  This study identifies GPR30 in spinal cholecystokinin-positive neurons as a molecular component of nerve-injury-induced pain sensitization. By combining cell-specific receptor manipulation, synaptic physiology, circuit tracing, and chemogenetics, it connects spinal AMPA-receptor transmission with a primary somatosensory cortex–dorsal horn pathway, while also defining important limits on how directly the circuit mechanism has been demonstrated.

• CX-5461 Workflow for RNA Polymerase I Inhibition

  2026-08-12

  Build a reproducible CX-5461 workflow around Pol I-driven rRNA suppression, cytostasis, autophagy, and DNA-damage readouts. The approach also translates recent cervical cancer findings into practical combination-testing and troubleshooting strategies.

• BHPF–GPER Binding and Neuroblastoma Apoptosis

  2026-08-11

  A 2024 Environmental Science & Technology study identified fluorene-9-bisphenol (BHPF) as a suspected GPER inhibitor rather than a receptor agonist. By combining molecular dynamics, receptor mutagenesis, knockout experiments, calcium imaging, and cytotoxicity assays, the work connected direct receptor recognition with disrupted GPER signaling in human neuroblastoma cells.

• Baicalin: An Assay-First Guide to Adult Plasticity

  2026-08-11

  Baicalin is emerging as a pharmacological tool for reopening adult visual-cortex plasticity. This assay-first guide interprets the latest amblyopia findings, clarifies mechanism-specific controls, and connects cortical plasticity research with broader cancer research applications.

• URB597: From FAAH Control to Pain Translation

  2026-08-10

  URB597 (KDS-4103) offers a precise way to interrogate FAAH and anandamide biology while keeping translational researchers focused on target engagement, tissue context, and affective pain outcomes. This article connects selective FAAH pharmacology with recent evidence that cannabidiol can influence sensory, inflammatory, emotional, and cognitive dimensions of pain.

• PMSF for Protein Extraction and Western Blotting

  2026-08-09

  Phenylmethanesulfonyl fluoride (PMSF) provides fast, targeted protection against serine proteolysis during cell and tissue lysis. This guide connects practical PMSF workflows with the ferroptosis-focused cardiomyopathy study of Praeruptorin A, showing how better sample preservation can strengthen DMT1, iron, and protein-signaling assays without confusing PMSF with a ferroptosis-modulating treatment.

• TBST: From Clean Blots to Translational Insight

  2026-08-08

  TBST is more than a routine wash solution: its buffering and nonionic detergent chemistry can shape background, antibody accessibility, and confidence in translational immunoassays. This thought-leadership guide connects TBST workflow control with mechanistic oncology research while defining its practical value and limitations.

8046 records 8/537 page Previous Next First page 上5页 678910 下5页 Last page